.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent findings highlight the significant First-Tier Exome Sequencing Utility for managing children with suspected rare genetic diseases. Specifically, a simulation of 523 patients showed that starting with exome sequencing (ES) improves clinical outcomes. Researchers used 'post-exome testing decision change' (P-TDC) to measure how ES results influence diagnostic pathways. This metric effectively quantifies the tests physicians order or avoid based on genomic data.
The study found a high P-TDC of 0.94 for first-tier ES. In addition, delayed testing reduced this clinical utility score to just 0.71. Early sequencing also proved most economical, costing approximately $3,414 per patient. Conversely, delayed strategies increased healthcare costs to over $10,026. Therefore, first-tier ES provides a consistent diagnostic yield while accelerating targeted treatment pathways for families.
Late testing extended the time to diagnosis by over three years in many cases. This delay often results in a costly and exhausting diagnostic odyssey. However, early implementation helps doctors bypass expensive and unnecessary investigations. Consequently, many international clinical guidelines now support genomic sequencing as a primary tool for pediatric rare diseases.
Post-exome testing decision change (P-TDC) measures clinical utility by quantifying how exome sequencing results influence the physician's decision to order or avoid further diagnostic tests.
By providing a diagnosis earlier, it avoids a lengthy and expensive \"diagnostic odyssey\" involving multiple lower-yield tests, thereby reducing overall healthcare expenditure.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice and is not intended to replace professional judgment in diagnosis or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Tagimacruz T et al. Clinical Utility of Exome Sequencing: Post-Exome Testing Decision Changes in the Management of Children with Suspected Rare Genetic Disease. Genet Med. 2026 Jun 10. doi: undefined. PMID: 42273873.
American Academy of Pediatrics. Genetic Evaluation of the Child With Intellectual Disability or Global Developmental Delay. Pediatrics. 2024.
Makol A et al. Cost-effectiveness of genome sequencing for diagnosing patients with undiagnosed rare genetic diseases. Genet Med. 2021;23(11):2095-2104.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A recent study highlights the clinical utility of first-tier exome sequencing in pediatric rare diseases. Early testing achieved a 0.94 decision-change rate, reduced diagnostic time by over 3 years, and lowered costs to $3,414, proving more effective than delayed diagnostic strategies.
last month
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
